FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/11/097640 [Registered on: 18/11/2025] Trial Registered Prospectively
Last Modified On: 17/11/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Homeopathy 
Study Design  Single Arm Study 
Public Title of Study   Use of homoeopathic medicines in the treatment of warts on skin  
Scientific Title of Study   Effect of Individualized Homoeopathic medicine in the Treatment of Cutaneous Warts using Synthesis Repertory:An Open Label Prospective Clinical Study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Monika Somashekar 
Designation  PGT Trainee 
Affiliation  National Institute of Homoeopathy 
Address  OPD Room No 10,Department of Repertory,National Institute of Homoeopathy,Block GE,Sector 3,Salt Lake,Kolkata

Kolkata
WEST BENGAL
700106
India 
Phone  7013416270  
Fax    
Email  monikasomashekar33@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Avijit Shee Burman 
Designation  Professor  
Affiliation  National Institute of Homoeopathy 
Address  OPD Room No 10,Department of Repertory,National Institute of Homoeopathy,Block GE,Sector 3,Salt Lake,Kolkata

Kolkata
WEST BENGAL
700106
India 
Phone  9433392108  
Fax    
Email  asheeburman@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Avijit Shee Burman 
Designation  Professor  
Affiliation  National Institute of Homoeopathy 
Address  OPD Room No 10,Department of Repertory,National Institute of Homoeopathy,Block GE,Sector 3,Salt Lake,Kolkata

Kolkata
WEST BENGAL
700106
India 
Phone  9433392108  
Fax    
Email  asheeburman@gmail.com  
 
Source of Monetary or Material Support  
National Institute of Homoeopathy 
 
Primary Sponsor  
Name  National Institute of Homoeopathy 
Address  National Institute of Homoeopathy,Block GE,Sector 3,Salt Lake,Kolkata-700106,West Bengal,India 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Monika Somashekar  National Institute Of Homoeopathy  OPD No 10,Department of Repertory,Block GE,Sector 3,Saltlake,Kolkata
Kolkata
WEST BENGAL 
7013416270

monikasomashekar33@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
National Institute Of Homoeopathy Institutional Ethical Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: L088||Other specified local infections of the skin and subcutaneous tissue,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Individualized Homoeopathic medicine  Indicated individualized homoeopathic medicine will be prescribed after the repertorisation of the case using rubrics within synthesis repertory.Dose,Frequency of the selected medicine will be as per the susceptibility of the case.Follow up will be done monthly till 6 months from the baseline 
Comparator Agent  NIL  NIL 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  Patients suffering from warts diagnosed clinically
Patients having age between 18 to 65 years.
Patients of any sex, all the religions and of different socioeconomic status.
Patients able to read or understand English,hindi,bengali.
Patients willing to take part in the study and for regular follow ups.

 
 
ExclusionCriteria 
Details  Presence of skin diseases that may interfere with assessment like skin tag, moles, dyshidrotic eczema.
Patients having uncontrolled systemic inflammatory medical condition like SLE, RA, Psoriasis
Pregnant and lactating women.
Patients currently undergoing other forms of treatment for warts like allopathic, ayurvedic treatment
Patients having immune compromised condition.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Cutaneous Warts(cwarts) diagnostic score  Baseline and 6 months 
 
Secondary Outcome  
Outcome  TimePoints 
Collecting Socio demographic data of warts patients & their statistical analysis   Baseline & 6 months 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   30/11/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   1.Cutaneous warts are benign, spontaneously regressing, epithelial tumour’s differing in clinical morphology and histological pattern depending on the inducing human papilloma virus types.
2.Samples will be selected following preliminary and detailed screening using specified selection criteria.
3.Inclusion and exclusion criteria are strictly followed.
4.After consideration of dropout cases, a minimum 40 patients will be enrolled for the study.
5.Case-taking will be done as per the strict homoeopathic principle.
6.Baseline scoring will be taken using CWARTS diagnostic tool.
7.Analysis and evaluation of each case will be done.
8.Miasmatic analysis will be done.
9.Repertorization will be done in Synthesis Repertory.
10.Final selection of the remedy will be done after consultation with Materia Medica.
11.Potency, dose and repetition of the indicated remedies will be guided strictly as per homoeopathic principles.
12.General (non-medicinal) management including appropriate diet and regimen will be advised.
13.Subsequent prescriptions (follow-ups) will be generated according to relevant homoeopathic principles and will be recorded in follow-up sheets.
14.The baseline data will be compared with the data obtained in 6th month.
15.The score obtained by the patients will be compared and result will be analyzed as per appropriate statistical methods and interference will be done thereafter.
Powered by
 
Close